RESULTS OF 96-WEEK FOLLOW-UP AFTER DISCONTINUATION OF NUCLEOS(T)IDE ANALOGUE THERAPY IN CHRONIC HEPATITIS B GENOTYPE D REGION (NUCSTOP STUDY)

被引：0
|
作者：
Kiremitci, Sercan
Seven, Gulseren
Keskin, Elmas Biberci
Koker, Ibrahim H.
Kochan, Koray
Senturk, Hakan
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1520
引用
收藏
页码：S1361 / S1361
页数：1
相关论文
共 50 条
  • [21] 48 weeks outcome after cessation of nucleos(t)ide analogue therapy in chronic hepatitis B patients
    Gao, Li
    Hu, Yue
    Shi, Xiaofeng
    Li, Xin
    Zhang, Dazhi
    Ren, Hong
    ANNALS OF HEPATOLOGY, 2020, 19 (03) : 329 - 334
  • [22] Chronic hepatitis B: a scoping review on the guidelines for stopping nucleos(t)ide analogue therapy
    Hui, Rex Wan-Hin
    Mak, Lung-Yi
    Seto, Wai-Kay
    Yuen, Man-Fung
    Fung, James
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 17 (05) : 443 - 450
  • [23] LONG-TERM FOLLOW UP IDENTIFIES A HIGHER INCIDENCE OF FUNCTIONAL CURE FOLLOWING NUCLEOS(T)IDE ANALOGUE DISCONTINUATION IN HBEAGNEGATIVE CHRONIC HEPATITIS B
    Hume, Simon
    Hall, Samuel
    Burns, Gareth
    Tassone, Daniel
    Desmond, Paul
    Ratnam, Dilip
    Sinclair, Marie
    Sievert, William
    Levy, Miriam
    Sawhney, Rohit
    Nicoll, Amanda
    Valaydon, Zina
    Strasser, Simone
    Ngu, Meng
    Meredith, Christopher
    Matthews, Gail
    Visvanathan, Kumar
    Holmes, Jacinta
    Thompson, Alexander
    HEPATOLOGY, 2024, 80 : S218 - S219
  • [24] Combination therapy with a nucleos(t)ide analogue and interferon for chronic hepatitis B: simultaneous or sequential
    Enomoto, Masaru
    Tamori, Akihiro
    Nishiguchi, Shuhei
    Kawada, Norifumi
    JOURNAL OF GASTROENTEROLOGY, 2013, 48 (09) : 999 - 1005
  • [25] Combination therapy with a nucleos(t)ide analogue and interferon for chronic hepatitis B: simultaneous or sequential
    Masaru Enomoto
    Akihiro Tamori
    Shuhei Nishiguchi
    Norifumi Kawada
    Journal of Gastroenterology, 2013, 48 : 999 - 1005
  • [26] Predictors for Efficacy of Combination Therapy with a Nucleos(t) ide Analogue and Interferon for Chronic Hepatitis B
    Li, Hong
    Wang, Hua
    Peng, Cheng
    Zheng, Xin
    Liu, Jia
    Weng, Zhi-hong
    Yang, Dong-liang
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2017, 37 (04) : 547 - 555
  • [27] INCIDENCE FOR LOSS-TO-FOLLOW-UP IN PATIENTS WITH CHRONIC HEPATITIS B DURING LONG-TERM NUCLEOS(T)IDE ANALOGUE THERAPY
    Su Chung-Wei
    Yen-Chun Liu
    Chien-Wei Peng
    Wen-Juei Jeng
    Rong-Nan Chien
    Yun-Fan Liaw
    HEPATOLOGY, 2022, 76 : S289 - S290
  • [28] Stopping Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B
    Liaw, Yun-Fan
    GASTROENTEROLOGY, 2020, 159 (03) : 1186 - 1186
  • [29] Outcome of chronic hepatitis B patients who discontinued nucleos(t)ide analogue therapy
    Yapali, Suna
    Oberhelman, Kelly
    Lok, Anna S.
    HEPATOLOGY, 2014, 60 : 1114A - 1115A
  • [30] Predictors for Efficacy of Combination Therapy with a Nucleos(t)ide Analogue and Interferon for Chronic Hepatitis B
    李红
    王华
    彭程
    郑昕
    刘嘉
    翁志宏
    杨东亮
    Current Medical Science, 2017, (04) : 547 - 555
12345